{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:11:07Z","timestamp":1778278267240,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jaad.2017.08.046","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T02:29:41Z","timestamp":1513045781000},"page":"217-219.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Drug-associated hidradenitis suppurativa: A systematic review of case reports"],"prefix":"10.1016","volume":"78","author":[{"given":"John W.","family":"Frew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dunja A.","family":"Vekic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane A.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey D.","family":"Cains","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2017.08.046_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12788\/j.sder.2017.017","article-title":"Pathophysiology of hidradenitis suppurativa","volume":"36","author":"Hoffman","year":"2017","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2017.08.046_bib2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"10.1016\/j.jaad.2017.08.046_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaad.2017.08.046_bib4","unstructured":"Frew JW, Vekic DA, Woods J, Cains GD. Drug-associated hidradenitis suppurativa\/acne inversa: a systematic review of case reports with insights into pathogenesis of disease. PROSPERO 2016: CRD42016051943. Available at: http:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.asp?ID=CRD42016051943. Accessed July 4, 2017."},{"key":"10.1016\/j.jaad.2017.08.046_bib5","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2017.08.046_bibS1","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/0002-9343(84)90356-5","article-title":"Side effects of systemic cyclosporine in patients not undergoing transplantation","volume":"77","author":"Palestine","year":"1984","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.jaad.2017.08.046_bibS2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/09546634.2015.1094179","article-title":"Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa","volume":"27","author":"Delobeau","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2017.08.046_bibS3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0190-9622(95)90410-7","article-title":"Lithium therapy associated with hidradenitis suppurativa: case report and review of the dermatologic side effects of lithium","volume":"32","author":"Gupta","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.046_bibS4","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/2013.jamadermatol.23","article-title":"Hidradenitis suppurativa, eruptive melanocytic naevi and keratosis pilaris like eruption in a patient treated with vemurafenib","volume":"148","author":"Ma","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.08.046_bibS5","first-page":"427","article-title":"Acne inversa like skin lesions as a potential adverse event during vemurafenib therapy","volume":"14","author":"Thiem","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2017.08.046_bibS6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MPG.0b013e3182474d78","article-title":"First episode of axillary acne inversa in a teenager on infliximab therapy for Crohn disease","volume":"56","author":"Savasan","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaad.2017.08.046_bibS7","first-page":"307","article-title":"Lithium induced hidradenitis suppurativa and acne conglobate","volume":"70","author":"Aithal","year":"2004","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2017.08.046_bibS8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2340\/0001555577483","article-title":"Lithium therapy associated with hidradenitis suppurativa","volume":"77","author":"Marinella","year":"1997","journal-title":"Acta Derm Venereol"},{"issue":"suppl 10","key":"10.1016\/j.jaad.2017.08.046_bibS9","first-page":"2269","article-title":"SAPHO syndrome treated by TNF alpha-blocking agents. Report of 45 cases","volume":"62","author":"Hayem","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2017.08.046_bibS10","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jaad.2016.01.018","article-title":"Hidradenitis suppurativa: an unrecognized paradoxical effect of biologic agents used in chronic inflammatory diseases","volume":"74","author":"Faivre","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.046_bibS11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.298.6665.28","article-title":"Hidradenitis suppurativa associated with the use of oral contraceptives","volume":"298","author":"Stellon","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2017.08.046_bibS12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jdv.12438","article-title":"Use of biologic treatments in patients with hidradenitis suppurativa","volume":"29","author":"Martin-Ezquerra","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.08.046_bibS13","first-page":"152","article-title":"Undesirable side effects on the skin caused by lithium therapy\u2014case report and references","volume":"8","author":"Stamm","year":"1981","journal-title":"Pychiatr Prax"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217323095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217323095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T19:58:04Z","timestamp":1723665484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217323095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0190962217323095"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.08.046","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-associated hidradenitis suppurativa: A systematic review of case reports","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.08.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}